Novel Transcriptomic Signatures in Fibrostenotic Crohn’s Disease: Dysregulated Pathways, Promising Biomarkers, and Putative Therapeutic Targets
Inflammatory Bowel Diseases · 2025
DOI: 10.1093/ibd/izaf021 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Inflammatory Bowel Diseases, 2025. Verfasst von Animesh Acharjee und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. Hauptthemen laut MEDLINE: Crohn Disease, Transcriptome, Ileum, Ileal Diseases. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University Hospitals Birmingham NHS Foundation Trust.
Abstract (Originalsprache)
Background
Fibrosis is a common complication in Crohn’s disease (CD), often leading to intestinal strictures. This study aims to explore the transcriptomic signature of fibrostenotic ileal CD for a comprehensive characterization of biological and cellular mechanisms underlying intestinal fibrosis.
Methods
Nine CD patients undergoing surgery for fibrotic ileal strictures were prospectively recruited. RNA was extracted from fresh resected samples for bulk transcriptomics. Differentially expressed genes (DEGs) were identified (adj. P value < .05), and machine learning analyses were employed to compare gene expression patterns between strictures and non-strictured margins. Pathway enrichment analysis pinpointed relevant pathways. Furthermore, a random forest model was constructed to evaluate the significance of targeted genes. Relevant genes were subsequently validated through qPCR and further analyzed using a publicly available bulk RNA-seq dataset (GSE192786). Single-cell RNA sequencing (scRNA-seq) analysis was performed using the 10× Chromium Controller platform.
Results
Bulk transcriptomics revealed unique transcriptomes with 81 DEGs, 64 significantly up-regulated, and 17 down-regulated in strictures compared to non-strictured margins. Up-regulated genes were mainly associated with inflammation, matrix and tissue remodeling, adipogenesis and cellular stress, while down-regulated genes were linked to epithelial barrier integrity. LY96, AKAP11, SRM, GREM1, EHD2, SERPINE1, HDAC1, and FGF2 showed high specificity for strictures. scRNA-seq linked up-regulated GREM1 exclusively to fibroblasts, while EHD2 and FGF2 showed upregulation in both fibroblasts and endothelial cells. LY96 and SRM were expressed by immune cells, whereas HDAC1, AKAP11, and SERPINE1 showed low expression across all cellular subsets.
Conclusions
This study comprehensively characterizes resected CD ileal strictures, elucidating main dysregulated pathways and identifying promising biomarkers and putative therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
- Centre for Health Data Research, University of Birmingham, Birmingham, UK.
- Gastroenterology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
- Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
- APC Microbiome Ireland, College of Medicine and Health, University College Cork, Cork, Ireland.
- Centre for Liver and Gastrointestinal Research, University of Birmingham, Birmingham, UK.
ORCID-Profile: Giovanni Santacroce, Marietta Iacucci, Subrata Ghosh
Förderung
- University Hospitals Birmingham NHS Foundation Trust
Zitieren
APA
Acharjee, A., Shivaji, U., Santacroce, G., Akiror, S., Jeffery, L., Varnai, C., Reynolds, G., Zardo, D., Majumder, S., Amamou, A., Gkoutos, G. V., Iacucci, M., & Ghosh, S. (2025). Novel Transcriptomic Signatures in Fibrostenotic Crohn’s Disease: Dysregulated Pathways, Promising Biomarkers, and Putative Therapeutic Targets. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izaf021
Vancouver
Acharjee A, Shivaji U, Santacroce G, Akiror S, Jeffery L, Varnai C, et al. Novel Transcriptomic Signatures in Fibrostenotic Crohn’s Disease: Dysregulated Pathways, Promising Biomarkers, and Putative Therapeutic Targets. Inflammatory Bowel Diseases. 2025. doi:10.1093/ibd/izaf021
BibTeX
@article{Acharjee2025,
author = {Acharjee, Animesh and Shivaji, Uday and Santacroce, Giovanni and Akiror, Sarah and Jeffery, Louisa and Varnai, Csilla and Reynolds, Gary and Zardo, Davide and Majumder, Snehali and Amamou, Asma and Gkoutos, Georgios V and Iacucci, Marietta and Ghosh, Subrata},
title = {Novel Transcriptomic Signatures in Fibrostenotic Crohn’s Disease: Dysregulated Pathways, Promising Biomarkers, and Putative Therapeutic Targets},
journal = {Inflammatory Bowel Diseases},
year = {2025},
doi = {10.1093/ibd/izaf021}
}
EUVIMED